Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (NASDAQ:SNGX)

2.11
Delayed Data
As of 3:59pm ET
 +0.02 / +0.96%
Today’s Change
1.90
Today|||52-Week Range
5.30
-6.22%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close2.09
Today’s open2.04
Day’s range2.04 - 2.11
Volume28,722
Average volume (3 months)140,259
Market cap$12.0M
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+55.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+19.16%
P/E ratioNM
Price/Sales0.77
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...-0.01-0.69%
NDRAENDRA Life Sciences ...+0.08+2.61%
CLSNCelsion Corp+0.06+1.57%
RXIIRxi Pharmaceuticals ...+0.07+11.82%
Data as of 4:00pm ET, 10/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$10.4M
Annual profit (last year)-$3.2M
Net profit margin-31.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer, Secretary &
Senior VP
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts